| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Jazz Pharmaceuticals plc | Director | Ordinary Shares | 6,933 | $771,297 | $111.25 | 08 Aug 2025 | Direct |
| ANAPTYSBIO, INC | Director | Restricted Stock Unit | 3,900 | $85,059 | $21.81 | 06 Jan 2023 | Direct |
| Y-mAbs Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $8.52 | 16 Sep 2025 | Direct |
| Scilex Holding Co | Director | Nonstatutory Stock Option (right to buy) | 250,000 | 17 Jan 2023 | Direct | ||
| ANAPTYSBIO, INC | Director | Stock Option (right to buy) | 10,600 | 06 Jan 2023 | Direct | ||
| ACCELERON PHARMA INC | Director | Common Stock | 0 | $29.37 | 19 Nov 2021 | Direct | |
| ACCELERON PHARMA INC | Director | Option to Purchase Common Stock | 0 | 19 Nov 2021 | Direct | ||
| PARDES BIOSCIENCES, INC. | Director | Stock Option (Right to Buy) | 0 | 31 Aug 2023 | Direct | ||
| Y-mAbs Therapeutics, Inc. | Director | Employee Stock Option (right to buy) | 0 | 16 Sep 2025 | Direct |